The Europe Colonoscope Market would witness market growth of 6.4% CAGR during the forecast period (2022-2028).
A family history of colon cancer or polyps could be a cause of the operation. It could increase the risk of acquiring cancer. A colonoscopy is a screening examination and a surgical procedure to remove polyps if found. Indications for colonoscopies are gastrointestinal bleeding, unexplained bowel habit changes, and suspicion of cancer. Colonoscopies are commonly performed to diagnose polyps and cancers of the colon, as well as inflammatory bowel disease. In older patients, even if no evident blood has been observed in the stool, an unexplained reduction in hematocrit (one symptom of anemia) warrants a colonoscopy, usually in conjunction with an EGD (feces).
Fecal occult blood is a simple test for detecting blood in the stool. A positive test result nearly invariably indicates the need for a colonoscopy. In most situations, a positive result is due to hemorrhoids; however, it can also be caused by diverticulosis, inflammatory bowel illness (Crohn's disease, ulcerative colitis), or polyps. Colonic polypectomy is now a standard component of colonoscopy, allowing for the noninvasive removal of polyps without invasive surgery.
Despite the prevalence of colon polyps, only about one in ten will proceed to cancer. Its growth is a gradual process that typically takes around ten years. This indicates that screening, prevention, and early diagnosis are viable options. In addition, the medical technology industry in the United Kingdom generates around $30 billion annually in revenue. It has a solid basis of predominantly small and medium-sized businesses nationwide, with activity centers in the South East of England and the Midlands. The increased incidence of colorectal cancer in the region and the expansion of the medical technology industry is expected to contribute to the expansion of the colonoscope market.
The Germany market dominated the Europe Colonoscope Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $115.6 Million by 2028. The UK market is anticipated to grow at a CAGR of 5.5% during (2022 - 2028). Additionally, The France market would exhibit a CAGR of 7.1% during (2022 - 2028).
Based on Application, the market is segmented into Colorectal Cancer, Ulcerative Colitis, Crohns Disease and Others. Based on End User, the market is segmented into Hospitals, Ambulatory Surgery Centers and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
Free Valuable Insights: The Worldwide Colonoscope Market is Projected to reach USD 1.7 Billion by 2028, at a CAGR of 6.8%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Medtronic PLC, Stryker Corporation, Olympus Corporation, Fujifilm Holdings Corporation, Ambu A/S, Boston Scientific Corporation, SonoScape Medical Corp., Daichuan Medical (Shenzhen) Co., Ltd. (EndoFresh), and EndoMed Systems GmbH.
By Application
By End User
By Country
Unique Offerings Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
